|  | Cancer | Skin Cancer

Purple Skin Lesions in Terminal Cancer: Evaluation and Differential Diagnosis

New purple skin lesions in a patient with terminal cancer require prompt clinical assessment. While concerning, they are not universally malignant.

Possible Causes

  • Metastatic deposits: Cutaneous metastases (breast, lung, melanoma, renal) can appear violaceous
  • Kaposi sarcoma: HHV-8 associated; violaceous patches/nodules; increased in immunosuppression
  • Vasculitis/leukocytoclastic vasculitis: Palpable purpura from immune complex deposition
  • Coagulopathy/bleeding: Thrombocytopenia, DIC, anticoagulants → ecchymoses, petechiae
  • Drug reactions: Chemotherapy agents (e.g., taxanes, bleomycin) can cause pigmentation or vasculitis
  • Radiation recall/dermatitis: In previously irradiated fields
  • Infection: Ecthyma gangrenosum (Pseudomonas), fungal angioinvasion
  • Benign: Cherry angiomas, venous lakes, trauma

Evaluation

  • History, medication review, physical exam (dermoscopy)
  • Biopsy if diagnosis uncertain
  • CBC, coagulation, inflammatory markers

Management

Directed at underlying cause. Palliative focus: comfort, bleeding control, infection prevention, cosmetic concern. Multidisciplinary coordination (oncology, dermatology, palliative care) optimizes quality of life.

Skin Cancer - Related Articles